Serial Number
77543711
Owner
VALEANT PHARMACEUTICALS LUXEMBOURG S.À.R.LAttorney
Robert J. GormanFiling Date
Aug 11, 2008
ORAMELT Trademark
Serial Number: 77543711 • Registration: 4247772
Trademark Classes
Owner Contact Info
13-15 AVENUE DE LA LIBERTÉ
LUXEMBOURG CITY 1931 , LU
Entity Type: 99
3013 LAKE DRIVE
DUBLIN 24 , IE
Entity Type: 99
Legal Representation
Correspondence Address
Robert J. Gorman
1400 N. Goodman Street
Law Department
Rochester, NY 14609
UNITED STATES
Trademark Details
Filing Date
August 11, 2008
Registration Date
November 27, 2012
Published for Opposition
September 11, 2012
Cancellation Date
June 28, 2019
Goods & Services
Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of disorders, diseases, conditions, and ailments of the central nervous system; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Parkinson's disease; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Huntington's disease; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of amyotrophic lateral sclerosis; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Alzheimer's disease; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of epilepsy; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of multiple sclerosis; pharmaceutical preparations and substances for the treatment of depression, depressive disorders and mental illnesses; antidepressants; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of anxiety; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of pain; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of disorders, diseases, conditions, and ailments of the cardiovascular system; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of cardiopulmonary disorders, diseases, conditions, and ailments; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of disorders, diseases, conditions, and ailments of the circulatory system; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of hypertension, angina, high blood pressure, heart failure and ventricular dysfunction; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of metabolic disorders, diseases, conditions, and ailments; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of diabetes; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of viral and infectious diseases; Drug delivery agents consisting of rapidly dissolving compounds, formulations, compositions and agents that facilitate delivery of a wide range of human and veterinary pharmaceuticals; and Drug delivery agents in the nature of pill coatings that facilitate delivery of a wide range of human and veterinary pharmaceuticals; Pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Tourette syndrome
